Welcome To Welox Pharma WHO-GMP | ISO 9001:2015
Translated into:
Welcome To Welox Pharma WHO-GMP | ISO 9001:2015
Introduction to Ceftawel T Injection
Ceftawel T Injection is a combination of Ceftazidime and Tazobactam, providing powerful broad-spectrum antibacterial activity for serious hospital-acquired and resistant bacterial infections.
Uses of Ceftawel T Injection
Treatment of severe bacterial infections in hospitalized patients
Effective for pneumonia, including ventilator-associated pneumonia
Indicated for sepsis, intra-abdominal infections, and urinary tract infections
Helps manage complicated skin and soft tissue infections
Provides reliable coverage against resistant Gram-negative pathogens
Benefits of Ceftawel T Injection
Broad-spectrum action against both Gram-positive and Gram-negative bacteria
Protects Ceftazidime from beta-lactamase degradation, extending activity against resistant bacteria
Hospital-grade infection control for severe and life-threatening conditions
Clinically proven efficacy in critically ill patients
Enhanced patient outcomes with rapid bacterial clearance
Mechanism of Action of Ceftawel T Injection
Ceftazidime inhibits bacterial cell wall synthesis, causing bacterial cell death.
Tazobactam blocks beta-lactamase enzymes, ensuring the effectiveness of Ceftazidime against resistant strains.
Together, they provide a potent combination that rapidly eliminates infection and prevents further spread.
For best results, use Ceftawel T Injection as prescribed by your healthcare professional. Store in a cool, dry place, and ensure proper handling by qualified medical staff.